NYSE:PRLB

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

US$2.5b

Last Updated

2021/06/23 04:11 UTC

Data Sources

Company Financials +

Executive Summary

Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. More Details


Snowflake Analysis

Flawless balance sheet with reasonable growth potential.


Similar Companies

Share Price & News

How has Proto Labs's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: PRLB is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: PRLB's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

6.2%

PRLB

-2.2%

US Machinery

-0.1%

US Market


1 Year Return

-16.1%

PRLB

51.1%

US Machinery

39.0%

US Market

Return vs Industry: PRLB underperformed the US Machinery industry which returned 50.8% over the past year.

Return vs Market: PRLB underperformed the US Market which returned 39% over the past year.


Shareholder returns

PRLBIndustryMarket
7 Day6.2%-2.2%-0.1%
30 Day2.0%-3.9%2.6%
90 Day-24.3%0.5%8.0%
1 Year-16.1%-16.1%54.4%51.1%41.2%39.0%
3 Year-23.3%-23.3%65.1%55.3%62.4%52.3%
5 Year60.1%60.1%159.1%133.2%132.3%106.2%

Long-Term Price Volatility Vs. Market

How volatile is Proto Labs's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Proto Labs undervalued compared to its fair value and its price relative to the market?

59.76x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: PRLB ($87.9) is trading above our estimate of fair value ($45.66)

Significantly Below Fair Value: PRLB is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: PRLB is poor value based on its PE Ratio (58.3x) compared to the US Machinery industry average (33.6x).

PE vs Market: PRLB is poor value based on its PE Ratio (58.3x) compared to the US market (19.2x).


Price to Earnings Growth Ratio

PEG Ratio: PRLB is poor value based on its PEG Ratio (2.5x)


Price to Book Ratio

PB vs Industry: PRLB's PB Ratio (3x) is in line with the US Machinery industry average.


Future Growth

How is Proto Labs forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

23.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: PRLB's forecast earnings growth (23.8% per year) is above the savings rate (2%).

Earnings vs Market: PRLB's earnings (23.8% per year) are forecast to grow faster than the US market (15.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: PRLB's revenue (10.1% per year) is forecast to grow faster than the US market (9.4% per year).

High Growth Revenue: PRLB's revenue (10.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if PRLB's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Proto Labs performed over the past 5 years?

5.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: PRLB has high quality earnings.

Growing Profit Margin: PRLB's current net profit margins (9.3%) are lower than last year (13.5%).


Past Earnings Growth Analysis

Earnings Trend: PRLB's earnings have grown by 5.3% per year over the past 5 years.

Accelerating Growth: PRLB's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: PRLB had negative earnings growth (-34.7%) over the past year, making it difficult to compare to the Machinery industry average (-6.4%).


Return on Equity

High ROE: PRLB's Return on Equity (5%) is considered low.


Financial Health

How is Proto Labs's financial position?


Financial Position Analysis

Short Term Liabilities: PRLB's short term assets ($158.5M) exceed its short term liabilities ($59.8M).

Long Term Liabilities: PRLB's short term assets ($158.5M) exceed its long term liabilities ($61.2M).


Debt to Equity History and Analysis

Debt Level: PRLB is debt free.

Reducing Debt: PRLB had no debt 5 years ago.

Debt Coverage: PRLB has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: PRLB has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Proto Labs's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate PRLB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PRLB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if PRLB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PRLB's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of PRLB's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average management tenure


CEO

Rob Bodor (47 yo)

0.25

Tenure

US$1,003,516

Compensation

Dr. Robert Bodor, also known as Rob, is a Co-Founder at Inveni, LLC and serves as its Chief Technical Officer. Dr. Bodor has been President and Chief Executive Officer and Director of Proto Labs, Inc. sinc...


CEO Compensation Analysis

Compensation vs Market: Rob's total compensation ($USD1.00M) is below average for companies of similar size in the US market ($USD5.35M).

Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: PRLB's management team is considered experienced (4.3 years average tenure).


Board Members

Experienced Board: PRLB's board of directors are considered experienced (4.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4%.


Top Shareholders

Company Information

Proto Labs, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Proto Labs, Inc.
  • Ticker: PRLB
  • Exchange: NYSE
  • Founded: 1999
  • Industry: Industrial Machinery
  • Sector: Capital Goods
  • Market Cap: US$2.497b
  • Shares outstanding: 27.69m
  • Website: https://www.protolabs.com

Number of Employees


Location

  • Proto Labs, Inc.
  • 5540 Pioneer Creek Drive
  • Maple Plain
  • Minnesota
  • 55359
  • United States

Listings


Biography

Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection mo...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/23 04:11
End of Day Share Price2021/06/22 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.